Cellectis SA (CLLS)
3.59
+0.09
(+2.57%)
USD |
NASDAQ |
Apr 10, 16:00
3.605
+0.02
(+0.42%)
After-Hours: 20:00
Cellectis EPS Diluted (Quarterly) : -0.2621 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| DBV Technologies SA | -1.170 |
| EDAP TMS SA | -0.2523 |
| Sanofi | -- |
| Akari Therapeutics Plc | 0.00 |
| Biodexa Pharmaceuticals Plc | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -26.30M |
| Revenue (Quarterly) | 10.39M |
| Total Expenses (Quarterly) | 36.69M |
| Enterprise Value | 272.36M |
| Gross Profit Margin (Quarterly) | 50.92% |
| Profit Margin (Quarterly) | -253.1% |
| Earnings Yield | -18.86% |
| Normalized Earnings Yield | -16.11 |